New Jersey's S 2260 strengthens legal protections for patients and providers accessing or delivering reproductive and gender-affirming health care services within the state. The bill explicitly defines "legally protected health care activities" to include seeking, providing, or assisting with these services (such as abortion, contraception, or gender-affirming care), regardless of a patient's location. It prohibits obstruction, intimidation, or physical barriers at facilities offering these services and grants licensing boards authority to impose civil penalties for violations. This directly affects patients traveling to New Jersey for care (not available in their home states) and healthcare providers operating in these fields. The law codifies existing protections to prevent harassment or violence against these services, following increased threats and protests nationwide after the overturning of Roe v. Wade.
S 3412 would require certain social media platforms in New Jersey to display a black box warning about mental health risks to users, similar to health warnings on tobacco products. The bill targets platforms primarily designed for social connection (like Facebook or TikTok) that have users in New Jersey, excluding services focused on news, entertainment, or e-commerce. This requirement is based on findings that youth social media use exceeding three hours daily doubles risks of depression and anxiety, and platforms are aware of these harms. The warning must be displayed on platforms meeting the bill's definition of "covered social media platforms," affecting all users of those services in the state.
This bill establishes a Social Media Research Center at a New Jersey four-year public university selected by the Higher Education Secretary. The center will conduct research on social media's effects on youth mental health, develop online safety resources for public schools, and provide recommendations to state agencies. It will also administer grants for social media research using a peer-reviewed process modeled after the NIH, and require annual reports on its work. The bill directly affects New Jersey public universities (as hosts), public schools (through educational resources), and state agencies (by requiring data sharing).
S 1493 updates New Jersey's occupational therapy licensure requirements by clarifying definitions and expanding recognized practice areas. It directly affects licensed occupational therapists, assistants, and the Occupational Therapy Advisory Council by adding LGBTQIA+ health, pelvic health, disaster management, and other modern practice areas to the scope of "occupational therapy services." The bill defines key terms like "continuing competence" (requiring documented professional development for license renewal) and "occupational performance" (covering daily life skills and health). These changes ensure licensure rules align with current practice standards without altering eligibility or fees.
This bill authorizes New Jersey's Department of Health (DOH) to seek participation in the World Health Organization's Global Outbreak Alert and Response Network (GOARN), a global network for disease outbreak coordination. It directly affects the DOH and New Jersey's public health response system by enabling collaboration on outbreak detection, information-sharing, and emergency preparedness. Key provisions allow the DOH to communicate with GOARN, submit applications, designate contact points, and participate in trainings without creating new legal obligations or requiring additional funding beyond existing appropriations. The bill specifically clarifies it does not establish New Jersey's membership in the WHO or override federal law.
This bill requires all corn masa flour and wet corn masa products sold in New Jersey to be fortified with folic acid to help reduce the risk of neural tube defects, which disproportionately affect Latino communities. Manufacturers must add specific amounts of folic acid to dry flour and wet products and clearly label these ingredients on nutrition facts panels. The law allows the state health commissioner to grant exemptions for specific products or companies if necessary. By making these changes, the legislation aims to ensure that dietary staples common in Central and South American cuisines provide essential nutritional benefits comparable to other fortified grains.
This bill codifies protections for patients and providers accessing or offering legally permitted reproductive and gender-affirming health care in New Jersey. It prohibits obstructing or intimidating individuals at facilities providing these services - including blocking entrances, causing reasonable fear of harm, or threatening violence. The law defines "legally protected health care activity" to cover all such services lawful in New Jersey, regardless of a patient’s location, and applies to both in-state residents and out-of-state patients seeking care here. It expands existing safeguards by explicitly banning physical obstructions and threats at facilities offering these services.
This bill would require New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services without restrictions for beneficiaries experiencing infertility. It directly affects low-income New Jersey residents enrolled in Medicaid who seek infertility treatment. The key provision amends Medicaid law to explicitly include these services as a standard benefit, removing prior authorization requirements. This change would expand current coverage to ensure these treatments are accessible as routine care for eligible individuals.
This bill regulates pharmacy benefits managers (PBMs) and insurance carriers to increase transparency and fairness in prescription drug coverage. It requires carriers and PBMs to establish pharmacy and therapeutics committees with strict conflict-of-interest rules, prohibits commission-based PBM compensation (mandating flat fees instead), and mandates detailed reporting of PBM fees for insurance filings. The law directly affects insurers, PBMs, and pharmacies by changing how drug formularies (approved drug lists) are managed and how PBM costs are calculated and disclosed. Key provisions include banning preferential formulary placement for higher-cost drugs over lower-cost generics/biosimilars and requiring actuarial documentation for PBM compensation. The bill aims to reduce patient cost-sharing and ensure PBM compensation aligns with administrative costs.
This bill would prohibit social media platforms from promoting content related to eating disorders - such as diet products, extreme weight loss practices, or harmful eating behaviors - to users under 18. Platforms must conduct quarterly internal audits and annual independent audits to ensure their algorithms or features don’t contribute to eating disorders in children, and fix any issues within 30 days if identified. Small platforms with less than $100 million in annual revenue are exempt from the audit requirements. The bill does not hold platforms liable for user-generated content unless the platform paid to promote it (e.g., via advertisements).
